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Purpose:  To investigate whether allelic polymorphism of 
haptoglobin (Hp) is associated with premature rupture of 
membrane (PROM), the Hp phenotypes of pregnant women 
with PROM were analyzed. Patients and Methods: The Hp 
phenotypes of 221 pregnant Korean women (187 control and 
34 PROM patients) were determined by benzidine/hydrogen 
peroxide staining, following native polyacrylamide gel electro-
phoresis of hemoglobin-mixed sera. The Hp allele frequencies 
were calculated from the data of Hp phenotypes, and overall 
association with PROM was evaluated using Pearson Chi- 
Square test. Results: The polymorphic distribution of the 
patients cohort who underwent a normal delivery (control 
group) was similar to that of healthy Koreans. In contrast, 
however, patients with PROM showed significantly higher 
occurrence of the Hp 1-1 phenotype than control group (23.5% 
vs 8.0%). Hp 2-2 phenotype was lower in PROM cohort 
(38.2%) than in the control group (48.7%). The Hp
1 allele 
frequency in PROM group was significantly higher than that 
in the control group (0.426 vs 0.297, p = 0.034) with odds ratio 
of 1.762 (95% CI: 1.038 - 2.991). Conclusion: These findings 
suggest that pregnant Korean women who possess Hp
1 allele 
(expressed as Hp 1-1 phenotype) have higher incidence of 
PROM than women with Hp
2 allele (expressed as Hp 2-2 
phenotype). This is the first study that evaluated the signifi-
cance of Hp polymorphism with respect to the development 
of PROM. 
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INTRODUCTION
Premature rupture of membrane (PROM) is 
characterized by membrane rupture prior to the 
onset of full-term labor. PROM complicates appro-
ximately 8% of pregnancies at term.
1 The main 
clinical concern for PROM is a high risk of infec-
tious morbidity and mortality in newborns.
2 To 
reduce the risk of fetal and maternal complica-
tions, it is required to find specific biomolecules 
associated with development of PROM.
The membrane rupture is related to collagen 
destruction and programmed cell death in fetal 
membranes. The risk factors for PROM involve 
reproductive tract infection, cigarette smoking, 
and uterine overdistention, and various mediators 
of PROM, including matrix-degrading enzymes, 
prostaglandins and inflammatory cytokines, can be 
produced in the fetal membranes and deciduas.
1-3 
Recent studies suggest that reactive oxygen 
species (ROS) might damage connective tissues of 
chorioamnion and induce PROM.
3-5 However, the 
exact mechanism of PROM is still unclear.
Haptoglobin (Hp) is an acute phase protein 
which plays roles in the systemic host defense in 
response to inflammation.
6 The protein binds hemo-
globin (Hb), thereby protecting cells from oxida-
tive damage that occurs during hemolytic injury.
7 
In addition, Hp exerts an inhibitory effect on 
prostaglandin synthesis
8 and a stimulatory effect 
on differentiation of endothelial cells.
9 Therefore, 
Hp is considered to have functions as an antioxi-
dant, immunomodulator and angiogenic factor.
Although it has been well-known that the main 
site of Hp biosynthesis is liver, several recent Haptoglobin Polymorphism in PROM 133
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studies demonstrated that the Hp protein is locally 
expressed in female reproductive organs such as 
the ovary, endometrium, and decidua.
10,11 The Hp 
can also be detected in amniotic fluid and vaginal 
fluid.
12 In addition, the plasma Hp level is elevated 
during pregnancy in a biphasic pattern with peaks 
in the first and third trimester.
13 These findings 
suggest that Hp may play a role in human repro-
duction and its activity may be involved in 
obstetric and gynecologic diseases. 
The human Hp gene has 2 major alleles, Hp
1 
and Hp
2, which are expressed as 3 major pheno-
types (Hp 1-1, Hp 2-2 and Hp 2-1). The Hp 1-1 and 
Hp 2-2 correspond to homozygote of the Hp
1 and 
Hp
2 alleles, respectively, while the Hp 2-1 is 
heterozygous for the two alleles (Hp
1/Hp
2).
14 It 
has been reported that the allelic polymorphism of 
Hp is associated with susceptibility and severity 
of specific diseases such as atherosclerosis, Par-
kinson's disease, gestational diabetes and preecl-
ampsia.
15-18
To date, the association of Hp with PROM has 
not been reported. To elucidate whether the Hp 
polymorphism is related to a high risk of PROM, 
we investigated the Hp phenotypes/genotypes of 
pregnant Korean women without or with PROM 
in the present study.
PATIENTS AND METHODS
Subjects
A total of 221 Korean term pregnant women 
were recruited into our study between 1 September 
2006 and 31 June 2007 at Kangnam St. Mary's 
hospital in Seoul, Korea. The patients were divided 
into 2 groups: Group 1 (PROM group) comprised 
34 pregnant women who delivered with PROM 
after 37 completed weeks of gestation, while Group 
2 (Control group) was composed of 187 normal 
term pregnant women without PROM. All women 
were non smokers with singleton pregnancy. 
There were neither signs of pregnancy-related 
diseases, except PROM, nor any history of medi-
cal treatments. Patients were diagnosed with 
membrane rupture when they demonstrated at 
least 2 of the following indices on speculum ex-
amination: vaginal pooling of fluid with or without 
Valsalva maneuver, a positive nitrazine paper test, 
or microscopic evidence of ferning on a dried 
vaginal smear. All patients signed a written consent 
form to donate blood for research purpose, which 
was approved by the Institutional Review Board 
of The Catholic University of Korea in Seoul.
Blood was collected from each patient at the 
time of delivery. Serum fraction was obtained 
from the blood by centrifugation and stored at 
-80°C until analysis. 
Hp phenotyping
Hp phenotypes of individuals were determined 
by benzidine/hydrogen peroxide staining after 
native polyacrylamide gel electrophoresis of Hp- 
hemoglobin (Hb) complexes.
19 Briefly, the Hp in 
serum was converted into Hp-Hb complex by 
mixing 15 μL of serum with excess Hb, and electro-
phoresed on 8% native polyacrylamide gel. After 
electrophoresis, the gel was soaked in 1% benzi-
dine /20% acetic acid solution, and a small amount 
of hydrogen peroxide was immediately added to 
it while shaking. The bands representing Hp-Hb 
complexes in the gel could be visualized by the 
peroxidase activity of Hb. In the resultant electro-
phoretic pattern, Hp 1-1 type shows only a single 
band, whereas Hp 2-2 type shows slow-migrating 
polymer bands. Hp 2-1 type represents both 1-1 
type and polymer forms.
19
Statistics
Data were analyzed by 2-tailed Student's test 
and expressed as mean ± standard deviation (SD). 
The Hp allele frequencies were calculated from the 
data of Hp phenotypes, and overall association 
with PROM was evaluated using Pearson Chi- 
Square test. All statistical calculations were per-
formed by the SPSS 12.0 program for Windows. 
P < 0.05 was considered statistically significant. 
RESULTS
To analyze Hp phenotypes, 34 pregnant women 
who suffered from PROM and 187 pregnant women 
who underwent normal delivery were recruited. 
There were no significant differences between the Jin-Kyung Cho, et al. 134
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Table 1. Clinical Characteristics of Patients
Group 1  Group 2
PROM (n = 34) Control (n = 187)
Nullipara, n (%)  23 (67.6%) 114 (61%) 
Age (yrs) 31.5 ± 3.3  31.8 ± 3.5 
Gestational age at delivery (wks) 39.3 ± 1.1 39.3 ± 1.6
Neonatal birth weight (kg)  3.3 ± 0.4  3.2 ± 0.4
5 min Apgar score   9.4 ± 0.6   9.4 ± 0.9
PROM, premature rupture of membrane; Group 1 (PROM), patients who delivered with PROM; Group 2 (Control), patients who 
delivered without PROM. 
Values are given as mean ± SD or percentages.
Table 2. Haptoglobin Polymorphism i n  P r e g n a n t  W o m e n
Group 1 Group 2
p  value*
PROM, n (%) Control, n (%)
Hp 1-1  8 (23.5) 15 (8.0) 0.006
Hp 2-1 13 (38.2) 81 (43.3)
Hp 2-2 13 (38.2)  91 (48.7)
Total, n (%)   34 (100.0） 187 (100.0)
PROM, premature rupture of membrane; Group 1 (PROM), patients who delivered with PROM; Group 2 (Control), patients who 
delivered without PROM; Hp, haptoglobin.
*Comparison between Hp 1-1 type and the other types by Pearson Chi-Square test.
PROM and the normal delivery (control) groups 
in the clinical characteristics such as nullipara, 
maternal age, gestational age at delivery, neonatal 
birth weight and Apgar score at 5 minutes (Table 
1).
As for Hp polymorphism, the pregnant women 
with normal delivery (control group) showed Hp 
1-1, 2-1, and 2-2 phenotypes at 8.0%, 43.3%, and 
48.7%, respectively (Table 2). The Hp phenotypic 
distribution in these women was found to be 
statistically similar to ratios in healthy Koreans.
20  
The distribution rate of Hp phenotype for total 
population enrolled in this study (n = 221) was 
also similar; 10.4%, 42.5%, and 47.1% for Hp 1-1, 
2-1 and 2-2, respectively. In contrast, however, 
patients with PROM demonstrated the Hp 1-1 
type at 23.5%, which is a significantly higher rate 
than 8.0% of control group. The percentage to 
express the Hp 2-2 type was lower in PROM 
cohort (38.2%) than in the control group (48.7%). 
By Pearson Chi-Square test, Hp 1-1 type was 
significantly prevalent in PROM group as 
compared with control (23.5% vs 8.0%, p = 0.006) 
with odds ratio of 3.528 (95% CI: 1.362 - 9.141) 
(Table 2).
The Hp allele frequencies were calculated from 
the distribution data for Hp phenotypes (Table 2) 
and evaluated using Pearson Chi-Square test. As 
shown in Table 3, the frequency of Hp
1 allele in 
the PROM group was significantly higher than 
that of the control group (0.426 vs 0.297, p =0 . 0 3 4 )  
with odds ratio of 1.762 (95% CI: 1.038 - 2.991). 
These findings suggest that term pregnant women 
with the Hp
1 allele have higher incidence of PROM 
than women with the Hp
2 allele.
DISCUSSION
Several studies have demonstrated the relation 
of Hp polymorphism with susceptibility and 
severity of clinical symptoms in specific disorders, Haptoglobin Polymorphism in PROM 135
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Table 3. The Frequency of Haptoglobin Allele in PROM and Control Groups
Hp allele
Frequency
Group 1  Group 2  p  value*
PROM Control 
Hp
1 0.426 0.297 0.034
Hp
2 0.574 0.703
PROM, premature rupture of membrane; Group 1 (PROM), patients who delivered with PROM; Group 2 (Control), patients who 
delivered without PROM; Hp, haptoglobin.
*Pearson Chi-Square test was performed between Group 1 and Group 2.
including angiopathies, diabetes, Parkinson's disease 
and preeclampsia.
15-18 However, to the best of our 
knowledge, the correlation between PROM and 
Hp has not yet been studied. In the present study, 
we found that the frequency of individuals 
afflicted with PROM was significantly higher in 
women expressing the Hp 1-1 than in women 
expressing the Hp 2-2, suggesting that individuals 
with the Hp
1 allele are more susceptible to PROM 
as compared to those with the Hp
2 allele (Tables 
2 and 3).
Hp proteins with the 3 phenotypes show pheno-
type-dependent functional differences in anti-oxi-
dant, anti-inflammatory and angiogenic activi-
ties;
7,9,21 Hp 1-1 has a higher anti-inflammatory 
activity than Hp 2-2. On the contrary, Hp 2-2 pos-
sesses more potent angiogenic activity compared 
to Hp 1-1 and plays a role more efficiently during 
angiogenic process, while Hp 2-1 shows an inter-
mediate activity. Although the exact mechanism 
involved in higher incidence of PROM in indi-
viduals with Hp 1-1 is not known yet, it is quite 
plausible to suggest that the lower angiogenic 
potential in carriers of Hp 1-1 may contribute less 
effectively to the repair of damaged connective 
tissues of chorioamnion and may develop PROM 
more easily.
Hp forms a stable Hp-Hb complex by irrever-
sible binding with Hb. The Hp-Hb ligand binds 
to CD163, which is known as a Hb scavenger 
receptor, and is endocytosed. Recent studies 
demonstrated that the binding of Hp-Hb complex 
to CD163 receptor increases the expression of anti- 
inflammatory modulators such as interleukin-10 
and heme oxygenase-1.
22 It was also reported that 
the CD163 surface ligation induces tyrosine kinase- 
dependent calcium mobilization as well as casein 
kinase II- and protein kinase C-dependent secre-
tion of proinflammatory cytokines (interleukin-6 
and interleukin-1β).
23 Kristiansen et al. (2001) 
reported that affinity of the Hp-Hb complex for 
CD163 was Hp phenotype-dependent;
24 the com-
plex of Hp 2-2 and Hb exhibits higher functional 
affinity for CD163 than the complex of Hp 1-1 and 
Hb, although both Hp 1-1 and Hp 2-2 can effici-
ently remove Hb through CD163 receptor. In addi-
tion, the role of Hp in inflammatory response is 
phenotype-dependent, showing that Hp 1-1 and 
Hp 2-2 make dominant Th2 response and Th1 
response, respectively.
21 Therefore, to understand 
higher incidence of PROM in the individuals with 
Hp 1-1, because of the reason that PROM is an 
inflammation-associated gestational disease, further 
studies are required, focusing mainly on the 
expression of inflammatory regulators via CD 163 
signaling in amniotic tissues or decidua. 
Preterm PROM is the cause of nearly half of all 
preterm delivery and a high risk factor of peri-
natal morbidity and mortality.
2 Because the patho-
physiologic processes involved in subclinical 
infection are considered to be similar in both term 
and preterm PROM, the evidences for term PROM 
in this study might be applied similarly to pre-
term PROM. Nevertheless, it is necessary to con-
firm exact relationship of Hp to preterm PROM. 
In conclusion, pregnant women with Hp 1-1 
type have higher incidence of PROM than those 
with other Hp types. To our best knowledge, this 
is the first study that evaluated the significance of 
Hp phenotype with respect to the development of 
PROM. The findings suggested that the Hp poly-
morphism may be potentially applied to the Jin-Kyung Cho, et al. 136
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prevention of PROM during pregnancy.
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